Redsense signs agreement and commences delivery to distributor in Switzerland
Redsense Medical has signed an agreement to sell the company's alarm system for detecting and minimizing blood leakage with the distributor Theramed AG in Switzerland. The first shipment of the company's most advanced alarm units, that can connect directly to dialysis machines, has already been sent to the distributor.
In May, Redsense Medical communicated that the company was intending to sign a distribution agreement with Theramed AG in Switzerland. This agreement is now finalized and signed by both parties.
As stated earlier, Theramed AG has the intention to deliver dialysis machines from the Japanese company Nikkiso together with the alarm system from Redsense. These dialysis machines are the first with a validated connection directly to the alarm system, which minimizes the risk of severe blood loss due to automatic shutdown of the blood flow by the machine if the alarm system detects a blood leakage.
The distributor has already placed the first purchase order for alarm systems equipped with the direct connection to dialysis machines, and the shipment has been sent to the distributor. It is the first shipment of alarm systems with this added functionality that Redsense Medical is delivering to a customer.
“It is satisfying that our distributor in Switzerland can commence delivery of an integrated solution for hemodialysis, including our industry-leading system for minimizing severe blood leakage. Being able to display this functionality in the field on a leading market such as Switzerland is an important step for the company”, says Redsense Medical's CEO Patrik Byhmer.
For more information, please contact
Patrik Byhmer, CEO Redsense Medical AB (publ)
Telephone: +46 (0) 35 - 10 60 30
This press release is a translation of the Swedish original that was published 2017-06-30, and it was previously posted exclusively on the Redsense Medical website. It was added to the Redsense news channel as a formatted document in September 2017 during the process of preparing the company for a list change to Nasdaq First North.
About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense system, a medical technology product used for monitoring and alarm in the case of blood leakage in connection with hemodialysis. Redsense solves one of the most serious remaining safety problems within hemodialysis – to quickly detect venous needle dislodgement and catheter leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.